Immunohistochemistry

Specificity comes from the primary antibody's selective binding to its target in a tissue section. Because the target remains associated with its original cellular and structural context, the resulting signal can be interpreted alongside tissue architecture rather than as an isolated molecular measurement. This connection helps distinguish where a protein occurs and compare its distribution among cells or tissue regions.

These two detection options convert antibody recognition into a visible readout in different ways. An enzyme-linked system produces a signal that can be examined with light microscopy, whereas a fluorescent system is examined by fluorescence microscopy. The choice therefore affects the microscopy used and how the detected target is visualized, while both preserve the link between molecular identity and tissue location.

Fixation preserves tissue for section examination, but its quality directly affects whether target information remains interpretable. Careful optimization helps maintain the relationship between antigen location and tissue structure. Controls provide a reference for judging whether the observed signal reflects specific target detection rather than an unreliable staining outcome. Together, these safeguards make comparisons across tissue regions more credible.

The workflow begins with preserved tissue sections, followed by application of a primary antibody to the selected target. An enzyme-linked or fluorescent detection system then generates the signal, which is examined using light or fluorescence microscopy. Interpretation compares signal location with tissue structure to assess protein distribution, cellular identity, or tissue organization.

It can support more than a simple location map. By showing how markers are distributed among cells and tissue regions, IHC can help characterize cell types, examine tissue organization, and investigate disease-associated changes or biological pathways. These observations connect molecular identity with tissue structure, allowing researchers to relate altered protein patterns to broader changes within a tissue.

In clinical settings, standardized staining patterns can support tumor classification and diagnosis. Their value comes from examining marker signals within preserved tissue architecture, rather than relying only on an isolated molecular result. Reliable use still depends on optimized fixation and careful controls, because interpretation requires confidence that the observed pattern is dependable.